Researchers will explore how the central nervous system and peripheral tissues rely on and affect one another in these types of diseases. Researchers will also study genetic models to identify targets to treat related diseases.
“Every day, we’re making new connections between University of Michigan researchers and potential industry partners, facilitated by our Fast Forward Medical Innovation team,” said Stephen Kunkel, PhD, senior associate dean for research at the University of Michigan Medical School. “With the ultimate goal of having a positive impact on patients, this collaboration with MedImmune is an opportunity for our researchers from multiple disciplines to work with a company whose strategies align with our deep strengths in diabetes and metabolic diseases.”
More articles on hospital-physician relationships:
Only 20% of physicians are engaged with leadership, survey shows
AMA honors 10 government officials for outstanding service in medicine, public health
University of Kentucky plans 3rd regional medical school
